Fate Therapeutics
IPOPublic · La Jolla, United States · Founded 2007 · $30.0M raised
- Headquarters
- La Jolla, California
- Employees
- 51–200
- Founded
- 2007
- Business Model
- B2B
- Website
- fatetherapeutics.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Series BNov 2009
- Rounds
- 1
- Type
- Public
About
Clinical-stage biopharmaceutical company developing iPSC-derived cellular immunotherapies for autoimmune diseases and cancer.
Summary
Fate Therapeutics is a Biotech company based in La Jolla, United States, founded in 2007. It has raised $30.0M in total across 1 round, most recently a $30.0M Series B round in Nov 2009. Investors include OVP Venture Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2024
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...